Skip to main content
. 2015 Apr 28;10(4):e0123973. doi: 10.1371/journal.pone.0123973

Table 2. LINE-1 methylation status by demographic and clinicopathologic features.

Variable N LINE-1 methylation % (SD) p-value
Age <65 y/o 73 64.6 (6.4) 0.019
 ≧65y/o 56 61.7 (7.6)
Sex, male 81 63.0 (6.6) 0.562
 Female 48 63.8 (7.8)
Tumor size≧5cm 48 62.2 (7.7) 0.156
 <5cm 81 63.9 (6.6)
Histology a
 WD 6 64.4 (4.3) 0.481
 MD 105 63.6 (6.6)
 PD 18 61.5 (9.8)
T stage
 T1 4 68.2 (3.5) 0.195
 T2 12 64.7 (6.8)
 T3 89 62.5 (6.3)
 T4 24 64.8 (9.6)
N stage
 N1 87 63.8 (6.3) 0.238
 N2 42 62.3 (8.5)
Perineural invasion
 No 86 63 (7.1) 0.499
 Yes 43 63.9 (6.9)
Vascular invasion
 No 83 63.4 (6.6) 0.769
 Yes 46 63.1(7.8)
Tumor location b
 Right 40 65 (6.3) 0.070
 Left 89 62.6 (7.3)

a WD, well-differentiated; MD, moderately differentiated; PD, poorly differentiated.

b Tumor location is divided according to sites to the right or left of the splenic flexure.